Impacts of DRG-Based Prepayment Reform on the Cost and Quality of Patients with Neurologic Disorders: Evidence from a Quasi-Experimental Analysis in Beijing, China

Multidisciplinary DRG management for rational medication in obstetrics: a cost analysis in Zhejiang Province

BACKGROUND

Zhejiang Province introduced diagnosis-related group (DRG) payment reform in 2020, covering all hospitalizations to reduce costs and improve services. However, its emphasis on financial indicators and overlooks the evaluation of medical rationality, especially for pregnant women. To bridge this gap, this study developed an obstetric multidisciplinary team (MDT) model in which pharmacists are integrated into prenatal decision-making. This represents a transformation from reactive cost control to proactive medication optimization.

METHODS

This study collected DRG data of obstetric patients from a hospital between 2020 and 2024. First, we descripted the overall DRG operational performance and identified OZ13 (Other Pregnancy-Related diseases, with General Complications and Comorbidities) as the target disease groups by the Boston Matrix analysis. Subsequently, we employed Spearman correlation and Kruskal-Wallis H tests to identify key cost drivers. Finally, we applied a generalized linear model with gamma distribution and log-link function to determine key factors influencing medical costs.

RESULTS

After the implementation of the multidisciplinary team management, the Time Consumption Index (TCI) decreased from 1.06 to 0.9 and the Cost Consumption Index (CCI) dropped from 1 to 0.91. Meanwhile, the Case Mix Index (CMI) increased to 0.51. The OZ13 group was selected for follow-up analysis using the Boston Matrix analysis because group exhibited decreased average hospitalization expenditure but an increased Cost Consumption Index. OZ13 group analysis revealed hospitalization costs strongly correlated with pharmaceutical costs (p = 0. 81, P < 0. 01), with significant expenditure differences between 2020 and 2024 (P < 0. 05). Furthermore, the generalized linear model identified several factors influencing hospitalization costs for OZ13 patients, including a history of recurrent miscarriage or IVF status, gestational weeks, parity, age, and length of hospital stay.

CONCLUSIONS

The research findings show that early pharmacist involvement in the multidisciplinary team management has positively impacted hospital functioning, including quality, efficiency, and costs. It identifies pharmaceutical costs as the main adjustable expenditure in OZ13 disease group and highlights the necessity of differentiated management for complex cases.

A study on the impact of DRG payment on physicians' prescribing behavior in China: a case study of a healthcare consortium in J City

As one of the effective strategies adopted by countries worldwide to mitigate the rapid growth of healthcare expenditures, the DRG (Diagnosis-Related Group) payment system has been implemented in developed Western countries for both outpatient and inpatient care, focusing on costs associated with medical technologies, ancillary services, nursing care, and other healthcare-related expenses. However, in China, the excessive rise in consumable medical costs, particularly for pharmaceuticals, remains a primary driver of unreasonable healthcare expenditure growth. This study takes a healthcare alliance in City J, China, encompassing primary, secondary, and tertiary public hospitals, as a case example. By combining qualitative interviews with quantitative research methods, it explores the impact of DRG payment on physician prescribing behaviors. The results indicate that the DRG payment system significantly influences physician prescribing practices, a finding that holds after a series of robustness checks. Moreover, the effect varies across hospitals of different levels, with the DRG payment system having a more pronounced impact on pharmaceutical costs for acute ischemic stroke cases with two or fewer comorbidities. Therefore, the DRG payment system holds significant implications for the rational allocation of healthcare resources in China.

The Impact of DRG-Based Payment Reform on the Efficiency of Medical Care for Patients with Myocardial Infarction: Evidence from Georgia

In Georgia, a prospective financing system for hospital services using diagnosis-related groups (DRGs) was introduced in 2022 to increase the efficiency and transparency of the healthcare system. The purpose of this study is to evaluate the impact of DRG-based hospital reimbursement on the efficiency of medical care for patients with myocardial infarction. Hospitalization data from three large hospitals in Georgia before and after the introduction of DRGs, covering the period from 2021 to 2024, were analyzed. The study found that the implementation of DRGs in cardiology hospitals reduced length of stay, readmission, and mortality rates. Although the prices for nosologies have increased, patients' direct out-of-pocket payments have decreased, thereby improving financial access to medical services. The introduction of the DRG payment system had a positive effect on patient financial accessibility.